• Skip to primary navigation
  • Skip to main content

National Forum

  • Home
  • About
    • Annual Business Meeting
    • 2026-27 Strategic Plan
    • National Forum Awards
    • Advisory Leadership Council
    • Board of Directors
    • A Public Health Action Plan to Prevent Heart Disease & Stroke
    • Team
    • Support
    • Careers
  • Collaborations
    • Awareness Months 2026
    • Community Pharmacists
    • Counter Cholesterol®
    • Hypertension Takedown™
    • Flu Prevention
    • Know Your Numbers
    • Million Hearts®
      • Million Hearts® Stakeholders Flu Vaccination Campaign
    • Move with the Mayor®
    • MWTM Cholesterol
    • MWTM Flu Immunization
    • Signature Reports
    • Stronger Hearts™
    • Value & Access
      • Shared Decision Guide-High Cholesterol
      • Shared Decision Guide-AFib
      • Resources
      • Joint Policy Statements
    • Value & Innovation Forum
  • Events
    • National Forum and Member Events
    • 2026 Annual Meeting – Unleashing Prevention’s Power: Improving Americans’ Heart, Kidney, Metabolic, and Brain Health
    • 2026 NF Discussion on Key Takeaways from the 2026​ Guideline on the Management of Dyslipidemia
    • 2026 Unseen and Untreated: Confronting the Connections Between Heart and Kidney Disease
    • 2026 Mid-Year Virtual Convening-Unleashing Prevention’s Power: Hypertension Takedown™
    • 2025 Annual Meeting – Championing a Heart-Healthy America
    • 2025 NF Discussion on New AHA/ACC High Blood Pressure Guideline
    • 2025 Mid-Year Virtual Convening – Hypertension Takedown™
    • 2025 Vital Conditions Office Hour with Dr. Bobby Milstein
    • Value & Access Briefings
    • Physical Activity, Fitness and Stretch Breaks
  • Members
    • Join the National Forum
  • Newsroom
  • Search Toggle
  • Skip to content

National Forum Supports Expanded Access to Anti-Obesity Medications

Posted on 01.28.25

The National Forum for Heart Disease and Stroke Prevention supports the Centers for Medicare and Medicaid Services’ proposal to recognize obesity as a chronic disease and expand Medicare and Medicaid coverage for anti-obesity medications (AOMs).  

This change aligns with the Treat and Reduce Obesity Act and addresses gaps in obesity care access, particularly in communities with limited treatment options. The National Forum highlights the health benefits of AOMs in preventing chronic conditions like heart disease and reducing healthcare costs.  

For details, read the full comments here. 

 

Categories: Blog, In the News, News Releases

Subscribe Here for National Forum
Meetings, Events, and Updates

1717 Pennsylvania Avenue, NW, Suite 1025, 10th Floor Washington, DC 20006
Phone: (866) 894-3500 Fax: (202) 330-5080
  • Legal
  • Financial
  • Sitemap
Copyright © 2026 National Forum for Heart Disease & Stroke Prevention. All Rights Reserved
  • Facebook
  • Twitter
  • YouTube
  • Instagram
Contact

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Name*